List of works - Ueli Nachbur

A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production

scientific article

A novel nucleotide oligomerisation domain 2 mutation in a family with Blau syndrome: Phenotype and function.

scientific article published in January 2017

A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity

scientific article published on 21 September 2020

A type III effector antagonizes death receptor signalling during bacterial gut infection

scientific article published on September 2013

CD95L pro-drug: a novel Swiss Army Knife in cancer therapy?

scientific article published on 8 December 2006

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.

scientific article

Distinct requirements for activation-induced cell surface expression of preformed Fas/CD95 ligand and cytolytic granule markers in T cells.

scientific article published on 12 September 2008

Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation

scientific article

Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis.

scientific article published on 20 April 2015

EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation

scientific article published on 13 January 2017

Hepatitis C virus-induced hepatocyte cell death and protection by inhibition of apoptosis

scientific article published on 27 June 2014

Hepatitis C-induced hepatocyte apoptosis following liver transplantation is enhanced by immunosuppressive agents

scientific article published on 11 May 2016

IAPs Regulate Distinct Innate Immune Pathways to Co-ordinate the Response to Bacterial Peptidoglycans

scientific article published in February 2018

In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8

scientific article

In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-κB and activation of caspase-8.

scientific article published on January 2016

Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells

scientific article published on 23 November 2016

Is BID required for NOD signalling?

scientific article published on 01 August 2012

Killing Lymphoma with Smac-Mimetics: As Easy as ABC?

scientific article published on April 2016

Lentiviral Vectors to Analyze Cell Death Regulators

scientific article published on January 2016

Linear ubiquitination prevents inflammation and regulates immune signalling

scientific article

Lymphotoxin α induces apoptosis, necroptosis and inflammatory signals with the same potency as tumour necrosis factor.

scientific article

NOD1 is required for Helicobacter pylori induction of IL-33 responses in gastric epithelial cells

scientific article

Posttranscriptional regulation of Fas (CD95) ligand killing activity by lipid rafts

scientific article published on 6 December 2005

Progranulin does not inhibit TNF and lymphotoxin-α signalling through TNF receptor 1.

scientific article published on 8 October 2013

RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer

scientific article published in December 2016

RIPK1 is not essential for TNFR1-induced activation of NF-kappaB.

scientific article published on 20 November 2009

Response to the letter to the editor

scientific article published on 01 April 2014

TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice.

scientific article

TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1

scientific article published on 23 December 2015

The NOD2 signaling in peripheral macrophages contributes to neuropathic pain development

scientific article published on 01 January 2019

The Ubiquitin Ligase XIAP Recruits LUBAC for NOD2 Signaling in Inflammation and Innate Immunity

article

Thiazolide-induced apoptosis in colorectal cancer cells is mediated via the Jun kinase-Bim axis and reveals glutathione-S-transferase P1 as Achilles' heel

scientific article

Thiazolides inhibit growth and induce glutathione-S-transferase Pi (GSTP1)-dependent cell death in human colon cancer cells

scientific article

XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures

scientific article published on 26 July 2019

XIAP discriminates between type I and type II FAS-induced apoptosis

scientific article

List of works by Ueli Nachbur

A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production

A novel nucleotide oligomerisation domain 2 mutation in a family with Blau syndrome: Phenotype and function.

A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity

A type III effector antagonizes death receptor signalling during bacterial gut infection

CD95L pro-drug: a novel Swiss Army Knife in cancer therapy?

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.

Distinct requirements for activation-induced cell surface expression of preformed Fas/CD95 ligand and cytolytic granule markers in T cells.

Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation

Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis.

EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation

Hepatitis C virus-induced hepatocyte cell death and protection by inhibition of apoptosis

Hepatitis C-induced hepatocyte apoptosis following liver transplantation is enhanced by immunosuppressive agents

IAPs Regulate Distinct Innate Immune Pathways to Co-ordinate the Response to Bacterial Peptidoglycans

In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8

In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-κB and activation of caspase-8.

Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells

Is BID required for NOD signalling?

Killing Lymphoma with Smac-Mimetics: As Easy as ABC?

Lentiviral Vectors to Analyze Cell Death Regulators

Linear ubiquitination prevents inflammation and regulates immune signalling

Lymphotoxin α induces apoptosis, necroptosis and inflammatory signals with the same potency as tumour necrosis factor.

NOD1 is required for Helicobacter pylori induction of IL-33 responses in gastric epithelial cells

Posttranscriptional regulation of Fas (CD95) ligand killing activity by lipid rafts

Progranulin does not inhibit TNF and lymphotoxin-α signalling through TNF receptor 1.

RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer

RIPK1 is not essential for TNFR1-induced activation of NF-kappaB.

Response to the letter to the editor

TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice.

TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1

The NOD2 signaling in peripheral macrophages contributes to neuropathic pain development

The Ubiquitin Ligase XIAP Recruits LUBAC for NOD2 Signaling in Inflammation and Innate Immunity

Thiazolide-induced apoptosis in colorectal cancer cells is mediated via the Jun kinase-Bim axis and reveals glutathione-S-transferase P1 as Achilles' heel

Thiazolides inhibit growth and induce glutathione-S-transferase Pi (GSTP1)-dependent cell death in human colon cancer cells

XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures

XIAP discriminates between type I and type II FAS-induced apoptosis